367 related articles for article (PubMed ID: 7657166)
1. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
[TBL] [Abstract][Full Text] [Related]
2. Functional properties of WT1.
Haber DA; Englert C; Maheswaran S
Med Pediatr Oncol; 1996 Nov; 27(5):453-5. PubMed ID: 8827073
[TBL] [Abstract][Full Text] [Related]
3. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells.
Nichols KE; Re GG; Yan YX; Garvin AJ; Haber DA
Cancer Res; 1995 Oct; 55(20):4540-3. PubMed ID: 7553624
[TBL] [Abstract][Full Text] [Related]
4. Induction of p21 by the Wilms' tumor suppressor gene WT1.
Englert C; Maheswaran S; Garvin AJ; Kreidberg J; Haber DA
Cancer Res; 1997 Apr; 57(8):1429-34. PubMed ID: 9108440
[TBL] [Abstract][Full Text] [Related]
5. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
[TBL] [Abstract][Full Text] [Related]
6. E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells.
Maheswaran S; Englert C; Lee SB; Ezzel RM; Settleman J; Haber DA
Oncogene; 1998 Apr; 16(16):2041-50. PubMed ID: 9572485
[TBL] [Abstract][Full Text] [Related]
7. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
[TBL] [Abstract][Full Text] [Related]
9. Physical and functional interaction between WT1 and p53 proteins.
Maheswaran S; Park S; Bernard A; Morris JF; Rauscher FJ; Hill DE; Haber DA
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5100-4. PubMed ID: 8389468
[TBL] [Abstract][Full Text] [Related]
10. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
11. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
12. The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53.
Stanhope-Baker P; Kessler PM; Li W; Agarwal ML; Williams BR
J Biol Chem; 2004 Aug; 279(32):33575-85. PubMed ID: 15155752
[TBL] [Abstract][Full Text] [Related]
13. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.
Englert C; Hou X; Maheswaran S; Bennett P; Ngwu C; Re GG; Garvin AJ; Rosner MR; Haber DA
EMBO J; 1995 Oct; 14(19):4662-75. PubMed ID: 7588596
[TBL] [Abstract][Full Text] [Related]
14. The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.
Lee TH; Moffett P; Pelletier J
Nucleic Acids Res; 1999 Jul; 27(14):2889-97. PubMed ID: 10390530
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
Lee YI; Kim SJ
DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
[TBL] [Abstract][Full Text] [Related]
16. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
Fraizer GC; Shimamura R; Zhang X; Saunders GF
J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
[TBL] [Abstract][Full Text] [Related]
17. Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype.
Duarte A; Caricasole A; Graham CF; Ward A
Br J Cancer; 1998; 77(2):253-9. PubMed ID: 9460996
[TBL] [Abstract][Full Text] [Related]
18. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
McCoy C; McGee SB; Cornwell MM
Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
[TBL] [Abstract][Full Text] [Related]
19. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
